mucus d
NDC 51316-345, guaifenesin, pseudoephedrine hydrochloride, tablet, multilayer, extended release, from CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED.
- Product NDC
- 51316-345
- Status
- Listed
- Labeler
- CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
- Dosage form
- TABLET, MULTILAYER, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA214407
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51316-345 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN1200 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51316-345-62 | 51316034562 | 4 BLISTER PACK in 1 CARTON (51316-345-62) / 6 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51316-345 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51316-345 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51316-345. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.